The US dermatology OTC medications market was valued at US$ 952.97 million in 2020 and is projected to reach US$ 1,124.56 million by 2028; it is expected to grow at a CAGR of 2.1% during 2021–2028.
The growth of the market is attributed to rising prevalence of skin abnormalities and increasing availability of dermatology medication over the counter (OTC). However, the side effects associated with OTC dermatology medication such as skin allergy hinder the growth of the market.
The US dermatology OTC medications market is expected to witness significant growth during the forecast period. The growth of the market is expected to be fastest due to rising prevalence of skin abnormalities and increasing availability of dermatology medication over the counter (OTC). For instance, as per to the American Academy of Dermatology Association, acne is the most common skin condition in the US, affecting ~50 million Americans annually. ~85% of people from the age group of 12–24 experience minor acne problems. Additionally, the COVID-19 has affected a large population in the US leading to an unprecedented surge in demand for popular OTC drugs. Consumers appear to be trying to address illness symptoms on their own, to avoid visiting clinic. Physical distancing and stay-at-home orders have forced consumer to shop differently. Also, continuous use of mask and constant handwashing has led to skin irritation, and maskne. Constant handwashing has led to increase in conditions such as skin dryness and eczema, this has led to increase in demand for dermatology OTC products.
US Dermatology OTC Medications Market Revenue and Forecast to 2028 (US$ Million)
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
US Dermatology OTC Medications Market Segmentation
By Product Type
- Tablets and Capsules
- Oils
- Gels
- Creams and Ointments
- Others
By Indication
- Dermatitis
- Acne
- Psoriasis
- Skin Bleaching
- Anti-Fungal
- Wart Remover
- Others
By Route of Administration
- Topical
- Oral
By Distribution Channel
- Online Distribution
- Hospital and Retail Pharmacies
- Super and Hyper Markets
Company Profiles
- Bausch Health Companies Inc
- Perrigo Company Plc
- Bayer AG
- Viatris Inc.
- Johnson and Johnson Services, Inc.
- LEO Pharma A/S
- GlaxoSmithKline Plc.
- Galderma
- Dr. Reddy's Laboratories
- Acella Pharmaceuticals, LLC

Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
This text is related
to segments covered.

Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
This text is related
to country scope.
1. Introduction
1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 US Dermatology OTC Medications Market – By Product Type
1.3.2 US Dermatology OTC Medications Market – By Indication
1.3.3 US Dermatology OTC Medications Market – By Route of Administration
1.3.4 US Dermatology OTC Medications Market – By Distribution Channel
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. US Dermatology OTC Medications Market Landscape
4.1 Market Overview
4.2 PEST Analysis
4.2.1 US: PEST Analysis
4.3 Expert Opinion
5. US Dermatology OTC Medications Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Prevalence of Skin Abnormalities
5.1.2 Increasing Availability of Dermatology Medication Over the Counter (OTC)
5.2 Market Restraints
5.2.1 Side Effects Associated with OTC Dermatology Medication
5.3 Market Opportunities
5.3.1 Growing OTC Market
5.4 Future Trends
5.4.1 Rising Adoption of Telemedicine
5.5 Impact Analysis
6. Dermatology OTC Medications– US Market Analysis
6.1 US Dermatology OTC Medications Market Overview
6.2 Market Positioning of Key Players
7. US Dermatology OTC Medications Market Analysis– Product Type
7.1 Overview
7.2 US Dermatology OTC Medications Market, by Product Type 2020 & 2028 (%)
7.3 Tablets and Capsules
7.3.1 Overview
7.3.2 US Tablets and Capsules Market Revenue and Forecasts to 2028 (US$ Mn)
7.4 Oils
7.4.1 Overview
7.4.2 US Oils Market Revenue and Forecasts to 2028 (US$ Mn)
7.5 Gels
7.5.1 Overview
7.5.2 US Gels Market Revenue and Forecasts to 2028 (US$ Mn)
7.6 Creams and Ointments
7.6.1 Overview
7.6.2 Creams and Ointments Market Revenue and Forecasts to 2028 (US$ Mn)
7.7 Others
7.7.1 Overview
7.7.2 Others Market Revenue and Forecasts to 2028 (US$ Mn)
8. US Dermatology OTC Medications Market Analysis – Indication
8.1 Overview
8.2 US Dermatology OTC Medications Market, By Indication 2020 & 2028 (%)
8.3 Dermatitis
8.3.1 Overview
8.3.2 US Dermatitis Market Revenue and Forecasts to 2028 (US$ Mn)
8.4 Acne
8.4.1 Overview
8.4.2 US Acne Market Revenue and Forecasts to 2028 (US$ Mn)
8.5 Psoriasis
8.5.1 Overview
8.5.2 US Psoriasis Market Revenue and Forecasts to 2028 (US$ Mn)
8.6 Skin Bleaching
8.6.1 Overview
8.6.2 US Skin Bleaching Market Revenue and Forecasts to 2028 (US$ Mn)
8.7 Anti-Fungal
8.7.1 Overview
8.7.2 US Anti-Fungal Market Revenue and Forecasts to 2028 (US$ Mn)
8.8 Wart Remover
8.8.1 Overview
8.8.2 US Wart Remover Market Revenue and Forecasts to 2028 (US$ Mn)
8.9 Others
8.9.1 Overview
8.9.2 US Others Market Revenue and Forecasts to 2028 (US$ Mn)
9. US Dermatology OTC Medications Market Analysis – Route of Administration
9.1 Overview
9.2 US Dermatology OTC Medications Market, By Route of Administration 2020 & 2028 (%)
9.3 Topical
9.3.1 Overview
9.3.2 US Topical Market Revenue and Forecasts to 2028 (US$ Mn)
9.4 Oral
9.4.1 Overview
9.4.2 US Oral Market Revenue and Forecasts to 2028 (US$ Mn)
10. US Dermatology OTC Medications Market Analysis – Distribution Channel
10.1 Overview
10.2 US Dermatology OTC Medications Market, By Distribution Channel 2020 & 2028 (%)
10.3 Online Distribution
10.3.1 Overview
10.3.2 US Online Distribution Market Revenue and Forecasts to 2028 (US$ Mn)
10.4 Hospital and Retail Pharmacies
10.4.1 Overview
10.4.2 US Hospital and Retail Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
10.5 Super and Hyper Markets
10.5.1 Overview
10.5.2 US Super and Hyper Markets Market Revenue and Forecasts to 2028 (US$ Mn)
11. Impact of COVID-19 Pandemic on US Dermatology OTC Medications Market
11.1 US: Impact Assessment of COVID-19 Pandemic
12. US OTC Dermatology Medications Market– Industry Landscape
12.1 Overview
13. Company Profiles
13.1 Bausch Health Companies Inc.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Perrigo Company plc
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Bayer AG
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Viatris Inc.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Johnson and Johnson Services, Inc.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 LEO Pharma A/S
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 GlaxoSmithKline plc.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Galderma
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Dr. Reddy's Laboratories
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 ACELLA PHARMACEUTICALS, LLC
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. Inorganic Developments Done by Companies
Table 2. Glossary of Terms, US OTC Dermatology Medications Market
LIST OF FIGURES
Figure 1. US Dermatology OTC Medications Market Segmentation
Figure 2. US Dermatology OTC Medications Market Overview
Figure 3. Creams and Ointments Segment by Product Type is Expected to Show Remarkable Growth During Forecast Period
Figure 4. US: PEST Analysis
Figure 5. Expert Opinion
Figure 6. US Dermatology OTC Medications Market Impact Analysis of Drivers and Restraints
Figure 7. Overview of US Dermatology OTC Medications Market
Figure 8. Market Positioning of Key Players in US Dermatology OTC Medications Market
Figure 9. US Dermatology OTC Medications Market, By Product Type 2020 & 2028 (%)
Figure 10. US Tablets and Capsules Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 11. US Oils Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 12. US Gels Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 13. US Creams and Ointments Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 14. US Others Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 15. US Dermatology OTC Medications Market, by Indication 2020 & 2028 (%)
Figure 16. US Dermatitis Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 17. US Acne Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 18. US Psoriasis Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 19. US Skin Bleaching Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 20. US Anti-Fungal Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 21. US Wart Remover Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 22. US Others Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 23. US Dermatology OTC Medications Market, by Route of Administration 2020 & 2028 (%)
Figure 24. US Topical Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 25. US Oral Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 26. US Dermatology OTC Medications Market, by Distribution Channel 2020 & 2028 (%)
Figure 27. US Online Distribution Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 28. US Hospital and Retail Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 29. US Super and Hyper Markets Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 30. Impact of COVID-19 Pandemic on OTC Dermatology Medications in the US
The List of Companies - US Dermatology OTC Medications Market
- Bausch Health Companies Inc
- Perrigo Company Plc
- Bayer AG
- Viatris Inc.
- Johnson and Johnson Services, Inc.
- LEO Pharma A/S
- GlaxoSmithKline Plc.
- Galderma
- Dr. Reddy's Laboratories
- Acella Pharmaceuticals, LLC
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.